Conditioning Regimen

DRUG8 trials

Conditions

ALS (Amyotrophic Lateral Sclerosis)Acute Myeloid Leukemia (AML)Atypical Chronic Myeloid LeukemiaChronic Myelomonocytic LeukemiaEnd-stage Renal DiseaseGraft Versus Host DiseaseGraft vs Host DiseaseHematologic Malignancies

Phase 1

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

CompletedNCT00063817

National Institute of Allergy and Infectious Diseases (NIAID)End-stage Renal Disease, Kidney Transplantation, Renal Transplantation

Start: 2003-06-30End: 2009-07-31Updated: 2017-12-27

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

CompletedNCT01379209

Regimmune CorporationGraft Versus Host Disease

Start: 2011-09-30End: 2017-04-30Updated: 2019-10-23

Phase 2

Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation

CompletedNCT00189488

Swedish Orphan BiovitrumGraft Versus Host Disease, Hematologic Malignancies

Start: 2005-12-31End: 2013-08-31Updated: 2014-09-15

Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis

NCT01238328

Tehran University of Medical SciencesMucopolysaccharidosis

Start: 2009-09-30End: 2012-12-31Target: 10Updated: 2012-06-04

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

CompletedNCT02876679

Assistance Publique - Hôpitaux de ParisGraft vs Host Disease

Start: 2017-04-06End: 2020-10-12Updated: 2020-11-20

Haplo-identical Natural Killer (NK) Cells to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

WithdrawnNCT04395092

Kiadis PharmaAcute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)

Start: 2020-11-13End: 2023-11-30Updated: 2021-06-22

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Active, not recruitingNCT04761770

Memorial Sloan Kettering Cancer CenterAtypical Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Overlapping Syndrome +2

Start: 2021-02-15End: 2027-02-01Updated: 2026-02-17

Unknown Phase

Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Enrolling by invitationNCT07539662

Institute of Hematology & Blood Diseases Hospital, ChinaALS (Amyotrophic Lateral Sclerosis)

Start: 2025-12-29End: 2027-12-01Target: 8Updated: 2026-04-20

Related Papers

Phase II Study of Longitudinal Geriatric Assessment with Risk-Adapted Interventions to Reduce Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation for Older Patients with Advanced Myeloid Malignancies

Blood2024-11-051 citations

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial.

2024-02-1916 citations

BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)

Blood2020-11-04